Objective
Bacterial meningitis is one of the most serious infections for infants and children, which is associated with acute complications and chronic morbidity. Untreated bacterial meningitis is highly fatal, leaving serious neurological sequelae in survivors and crippling children for their life. Because the prognosis worsens with delayed treatment, early detection aids clinician in providing a timely intervention, to institute, appropriate antibiotic therapy. However, detection of meningitis can be challenging due to the minimum symptomology of the disease and particularly in newborns and young infants, the most vulnerable since their immunological system is yet being developed, for their inability to communicate. Paediatricians have the daily challenge of diagnosing 2.5M infants younger of one year in Europe each year who may have only fever that may be caused by an infection and, although the incidence is relatively low, it can be meningitis. The only method to detect the presence or absence of the disease is a lumbar puncture, an invasive, cumbersome and time-consuming and cost-ineffective procedure that, in industrialised countries, is negative in 95% of cases.
The imperious need for quick, easy and cost-effective detection makes Neosonic (NS) a unique solution for non-invasively screen for bacterial meningitis in infants. The innovative and sophisticated precision-engineering system using high-frequency ultrasound is placed in the fontanel of the infant, the area of the skull where bones remain unwelded for babies. With the push of a button NS measures the number of White Blood Cells in the CerebroSpinal Fluid. Therefore, only if CSF WBC count is increased should an LP be performed and antibiotic treatment for meningitis be administered. Furthermore, NS allows to follow up patient treatment response by means of monitoring CSF WBC concentration, which decays with a positive response. Currently, repeated LPs for follow-up are rarely performed due to its associated risk
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine rheumatology
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- natural sciences physical sciences acoustics ultrasound
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
28014 Madrid
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.